Jean Michel Le Mellédo
Department of Psychiatry
University of Alberta
Edmonton
Alberta
Canada
Name/email consistency: high
- Pentagastrin-induced hemoconcentration in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol. Le Melledo, J.M., Perez-Parada, J., Morrow, J., Bellavance, F., Lara, N., Jahandar, F., Granger, R., Tait, G., McManus, K. J. Psychopharmacol. (Oxford) (2011)
- Paroxetine-induced increase in LDL cholesterol levels. Le Melledo, J.M., Mailo, K., Lara, N., Abadia, M.C., Gil, L., Van Ameringen, M., Baker, G., Perez-Parada, J. J. Psychopharmacol. (Oxford) (2009)
- Role of progesterone and other neuroactive steroids in anxiety disorders. Le Mellédo, J.M., Baker, G. Expert. Rev. Neurother (2004)
- Pulmonary and systemic nitric oxide measurements during CCK-5-induced panic attacks. Lara, N., Chrapko, W.E., Archer, S.L., Bellavance, F., Mayers, I., Le Mellédo, J.M. Neuropsychopharmacology (2003)
- Neuroactive steroids and anxiety disorders. Le Mellédo, J.M., Baker, G.B. J. Psychiatry. Neurosci (2002)
- Effect of medroxyprogesterone pretreatment on pentagastrin-induced panic symptoms in females with panic disorder. Le Mellédo, J., Jhangri, G.S., Lott, P., Tait, G.R., McManus, K., Geddes, M., Chrapko, W., Lara, N. Psychiatry. Res (2001)
- Arginine-vasopressin and oxytocin response to cholecystokinin-tetrapeptide. Le Mellédo, J.M., Bradwejn, J., Koszycki, D., Bellavance, F., Bichet, D. Peptides (2001)
- The influence of Type A behavior pattern on the response to the panicogenic agent CCK-4. Le Mellédo, J.M., Arthur, H., Dalton, J., Woo, C., Lipton, N., Bellavance, F., Koszycki, D., Boulenger, J.P., Bradwejn, J. J. Psychosom. Res (2001)
- Response to flumazenil in women with premenstrual dysphoric disorder. Le Mellédo, J.M., Van Driel, M., Coupland, N.J., Lott, P., Jhangri, G.S. Am. J. Psychiatry (2000)
